Table 1 Baseline characteristics of the study cohort (N = 145).
Patient characteristics | |
|---|---|
Mean age (years (SD)) | 57.3 (14.3) |
Gender (N female (%)) | 63 (43.4) |
BMI and obesity grading | |
Mean BMI (kg/m2 (SD)) | 26.4 (4.7) |
BMI < 25 kg/m2 (N (%)) | 57 (39.3) |
BMI 25–30 kg/m2 (N (%)) | 59 (40.7) |
BMI 30–35 kg/m2 (N (%)) | 21 (14.5) |
BMI 35–40 kg/m2 (N (%)) | 6 (4.1) |
BMI ≥ 40 kg/m2 (N (%)) | 2 (1.4) |
Comorbidities | N (%) |
No comorbidities | 33 (22.8) |
≥ 3 comorbidities | 74 (51.0) |
Metabolic diseases | 63 (43.4) |
Diabetes mellitus type 1 | 0 (0.0) |
Diabetes mellitus type 2 | 24 (16.6) |
Hypercholesterolemia | 27 (18.6) |
Hypertriglyceridemia | 2 (1.4) |
Cardiovascular disease | 58 (40.0) |
Arterial hypertension | 44 (30.3) |
Pulmonary disease | 27 (18.6) |
Chronic kidney disease | 10 (6.9) |
Chronic liver disease | 8 (5.5) |
Gastrointestinal disease | 20 (13.8) |
Malignancy | 17 (11.7) |
Immune suppression | 9 (6.2) |